Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | -25.00% | -25.00% | -14.29% |
03-25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
03-14 | Avecho to Push Forward with Phase III Trial of Anti-Insomnia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-14.29% | 8.37M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited
- Athenex Pharmaceutical Division Submits Avecho's Vitamin K Injection to US FDA